Alector, Inc. (ALEC) stock
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3069% below fair value
$2.54+0.09 (+3.67%)
Close on Nov 13, 2026Market cap $283.61MP/E 7.3Yield –
Alector total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Alector's total debt was $0 at Sep 30, 2026. For fiscal 2025 it was $10.06M, up 7.1% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.06M | +7.1% |
| FY2024 | Dec 31, 2024 | $9.39M | – |
| FY2023 | Dec 31, 2023 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0 | -100.0% |
| Q2 FY2026 | Jun 30, 2026 | $9.85M | +3.3% |
| Q1 FY2026 | Mar 31, 2026 | $9.77M | +3.2% |
| Q4 FY2025 | Dec 31, 2025 | $10.06M | +7.1% |
| Q3 FY2025 | Sep 30, 2025 | $9.61M | – |
| Q2 FY2025 | Jun 30, 2025 | $9.54M | – |
| Q1 FY2025 | Mar 31, 2025 | $9.46M | – |
| Q4 FY2024 | Dec 31, 2024 | $9.39M | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
See a number that looks wrong?